Detalhe da pesquisa
1.
Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 209(11): 1376-1391, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261723
2.
G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol
; 68(5): 537-550, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724371
3.
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.
Thorax
; 77(3): 247-258, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226205
4.
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
Circulation
; 142(15): 1464-1484, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698630
5.
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.
Int J Mol Sci
; 22(6)2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803922
6.
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 200(7): 910-920, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31042405
7.
Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking.
Am J Respir Cell Mol Biol
; 70(2): 140-143, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299796
8.
CD34 regulates the skeletal muscle response to hypoxia.
J Muscle Res Cell Motil
; 40(3-4): 309-318, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31222587
9.
BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial.
Am J Respir Crit Care Med
; 205(11): 1357-1360, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289736
10.
R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models.
Eur Respir J
; 57(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446610
11.
Preservation of von Willebrand Factor Activity With the ModulHeart Device.
JACC Basic Transl Sci
; 9(1): 33-42, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362340
12.
Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc
; 13(12): e032888, 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874078
13.
RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis via LOXL2 Mediated Mechanism.
bioRxiv
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746200
14.
Exploring Integrin α5ß1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical Studies.
bioRxiv
; 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38854025
15.
PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension.
JACC Basic Transl Sci
; 7(4): 384-403, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35540097